Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2019. Start Trial.
Date Value
October 29, 2026 1.891
October 28, 2026 1.891
October 27, 2026 1.891
October 26, 2026 1.891
October 23, 2026 1.891
October 22, 2026 1.891
October 21, 2026 1.891
October 20, 2026 1.891
October 19, 2026 1.891
October 16, 2026 1.891
October 15, 2026 1.891
October 14, 2026 1.891
October 13, 2026 1.891
October 12, 2026 1.891
October 09, 2026 1.891
October 08, 2026 1.891
October 07, 2026 1.891
October 06, 2026 1.891
October 05, 2026 1.891
October 02, 2026 1.891
October 01, 2026 1.891
September 30, 2026 1.891
September 29, 2026 1.891
September 28, 2026 1.891
September 25, 2026 1.891
Date Value
September 24, 2026 1.891
September 23, 2026 1.891
September 22, 2026 1.891
September 21, 2026 1.891
September 18, 2026 1.891
September 17, 2026 1.891
September 16, 2026 1.891
September 15, 2026 1.891
September 14, 2026 1.891
September 11, 2026 1.891
September 10, 2026 1.891
September 09, 2026 1.891
September 08, 2026 1.891
September 04, 2026 1.891
September 03, 2026 1.891
September 02, 2026 1.891
September 01, 2026 1.891
August 31, 2026 1.891
August 28, 2026 1.891
August 27, 2026 1.891
August 26, 2026 1.891
August 25, 2026 1.891
August 24, 2026 1.891
August 21, 2026 1.891
August 20, 2026 1.891

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Getinge AB 2.275
Xvivo Perfusion AB 3.008
Abbott Laboratories 3.540
AngioDynamics, Inc. 3.196
Alphatec Holdings, Inc. --

Price to Book Value Related Metrics

PS Ratio 2.066
Price 3.50
Earnings Yield -0.65%
Market Cap 81.46M
Operating PE Ratio 390.20